NeoGenomics, Inc. (OQ:NEO)

Business Focus: Medical & Diagnostic Laboratories

Apr 18, 2024 07:05 am ET
NeoGenomics Announces Senior Leadership Promotions
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced two promotions within its senior leadership team, effective immediately.
Apr 09, 2024 07:00 am ET
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its first quarter 2024 financial results on Tuesday, April 30, 2024. Company management will host a webcast and conference call that morning at 8:30 a.m. Eastern Time to discuss financial results and recent highlights.
Mar 27, 2024 08:30 am ET
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, April 5-10
Mar 20, 2024 07:00 am ET
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today released its 2023 Environmental, Social, and Governance (ESG) Report highlighting progress toward building a more sustainable, diverse, and equitable company that delivers except
Mar 01, 2024 07:05 am ET
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts.
Feb 20, 2024 04:05 pm ET
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 results for the period ended December 31, 2023.
Feb 01, 2024 07:05 am ET
NeoGenomics Signs Working with Cancer Pledge in Support of Employees
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that the Company has signed the Working with Cancer Pledge. By taking the pledge, NeoGenomics demonstrates its commitment to supporting team members living with or caring for a loved one with cancer. Additionally, the company aims to op
Jan 30, 2024 06:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  
Jan 30, 2024 09:15 am ET
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will continue to grow in the next several years. Multiple myeloma is a type of plasma cell cancer. Normal plasma cells are recognized as an important...
Jan 30, 2024 07:05 am ET
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its fourth quarter and full year 2023 financial results on Tuesday, February 20, 2024. Company management will host a webcast and conference call that day at 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Jan 26, 2024 12:29 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.    The...
Jan 22, 2024 06:20 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 22, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  
Jan 18, 2024 05:22 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.    The...
Jan 14, 2024 10:45 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 14, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Jan 10, 2024 03:17 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Jan 06, 2024 10:15 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  
Jan 02, 2024 05:16 pm ET
ROSEN, A LEADING NATIONAL FIRM, Encourages NeoGenomics, Inc. Investors to Inquire About Securities Class Action Investigation – NEO
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) resulting from allegations that NeoGenomics may have issued materially misleading business information to the investing public.
Jan 02, 2024 03:22 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Jan 02, 2024 07:05 am ET
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced the company will participate in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.
Dec 29, 2023 12:08 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Dec. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. 
Dec 28, 2023 08:10 am ET
NeoGenomics to Appeal Ruling
FORT MYERS, FL / ACCESSWIRE / December 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services company, today announced that NeoGenomics Laboratories, Inc., a subsidiary of NeoGenomics Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The initial determination is that Natera, Inc. demonstrated a likelihood that products using RaDaR technology infringe one Natera, Inc. patent. The order specifically allows patients already using RaDaR to continue the
Dec 05, 2023 08:00 am ET
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR® assay for minimal residual disease (MRD) will be presented at the 46th annual San Antonio Breast Cancer Symposium (SABCS).
Nov 14, 2023 07:00 am ET
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler 35th Annual Global Healthcare Conference in New York City.
Nov 06, 2023 04:05 pm ET
NeoGenomics Reports Third Quarter 2023 Results
Third Quarter Revenue Increased 18% to $152 Million
Oct 24, 2023 07:00 am ET
NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
Neo Comprehensive™ - Heme Cancers is a large and comprehensive next-generation sequencing panel with broad coverage of genes associated with blood cancers
Oct 17, 2023 09:20 am ET
NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
FT. MYERS, FL / ACCESSWIRE / October 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report its third quarter 2023 financial results on Monday, November 6, 2023. Company management will host a webcast and conference call that day at 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Aug 08, 2023 07:00 am ET
NeoGenomics Reports Second Quarter 2023 Results
Second Quarter Revenue Increased 18% to $147 Million
Jul 27, 2023 07:00 am ET
NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
FT. MYERS, FL / ACCESSWIRE / July 27, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, announced today that the Molecular Diagnostics Services Program (MolDx) has conveyed coverage for the RaDaR® assay, a personalized liquid biopsy for minimal residual disease (MRD) and recurrence detection.
Jul 18, 2023 07:10 am ET
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
FT. MYERS, FL / ACCESSWIRE / July 18, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report its second quarter 2023 financial results on Tuesday, August 8, 2023. Company management will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Jun 29, 2023 07:00 am ET
NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors
FT. MYERS, FL / ACCESSWIRE / June 29, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced the appointment of Elizabeth Floegel, Neil Gunn, and Tony Zook to its Board of Directors.
Jun 15, 2023 04:45 pm ET
NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage
FT. MYERS, FL / ACCESSWIRE / June 15, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that its RaDaR® assay, a personalized liquid biopsy for minimal/molecular residual disease (MRD) and recurrence detection, has obtained its first pan-cancer commercial coverage by Blue Shield of California.
Jun 09, 2023 03:30 pm ET
Lifshitz Law PLLC Announces Investigations of Iris Energy Limited (NASDAQ: IREN), F45 Training Holdings, Inc. (NYSE: FXLV), Generac Holdings Inc. (NYSE: GNRC), and NeoGenomics, Inc. (NASDAQ: NEO)
Iris Energy Limited. (NASDAQ: IREN) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Offering Documents in connection with the...
Jun 05, 2023 07:00 am ET
NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
FT. MYERS, FL / ACCESSWIRE / June 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced new data in support of its RaDaR® assay for the detection of molecular residual disease (MRD) and recurrence in patients with high-risk hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer.
Jun 01, 2023 07:00 am ET
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
FT MYERS, FL / ACCESSWIRE / June 1, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced the company will be participating in the upcoming Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California.
May 30, 2023 07:00 am ET
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
FT. MYERS, FL / ACCESSWIRE / May 30, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced new data supporting its cancer tests and treatment guidance tools will be showcased in five poster presentations at the 2023 American Society of Clinical Oncology (ASCO®) Annual Meeting taking place June 2-6 in Chicago, Illinois.
May 08, 2023 04:05 pm ET
NeoGenomics Reports First Quarter 2023 Results
First Quarter Revenue Increased 17% to $137 Million
May 03, 2023 07:00 am ET
NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / May 3, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced the company will be participating in the upcoming BofA Securities 2023 Healthcare Conference in Las Vegas, Nevada.
Apr 17, 2023 07:00 am ET
NeoGenomics to Announce First Quarter 2023 Financial Results
FT. MYERS, FL / ACCESSWIRE / April 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that it will release its first quarter 2023 financial results on Monday, May 8, 2023. Along with the release, NeoGenomics will host a webcast and conference call that day at 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Apr 11, 2023 07:00 am ET
NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / April 11, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that members of its management team will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023 at 11:00am ET.
Apr 06, 2023 07:00 am ET
NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023
FT. MYERS, FL / ACCESSWIRE / April 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that the company and its collaborators will present a total of nine abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2023 taking place April 14-19, 2023 in Orlando, Florida.
Mar 27, 2023 07:00 am ET
NeoGenomics to Host Investor Day on April 4, 2023
FT. MYERS, FL / ACCESSWIRE / March 27, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that the Company will host an Investor Day on Tuesday, April 4, 2023, starting at 8:00 am ET. The event will feature a presentation by NeoGenomics' executive team members and conclude with a Q&A session.
Mar 22, 2023 08:00 am ET
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a collaboration with the goal of accelerating the development of new cancer therapies and ultimately improving the lives of millions of cancer patients around the world. NeoGenomics will identify patients in real time who may be eligible for clinical trials based on biomarker status. Following initial c
Mar 17, 2023 05:00 pm ET
Lifshitz Law PLLC Announces Investigations of Generac Holdings Inc. (NYSE: GNRC), Veru Inc. (NASDAQ: VERU), The Gap, Inc. (NYSE: GPS), and NeoGenomics, Inc. (NASDAQ: NEO)
Generac Holdings Inc. (NYSE: GNRC) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with alleged materially false and misleading statements and omissions...
Mar 16, 2023 07:00 am ET
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
FT MYERS, FL / ACCESSWIRE / March 16, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today the commercial availability of the RaDaR® assay, a liquid biopsy test for molecular/minimal residual disease (MRD). MRD is the trace amounts of circulating tumor DNA (ctDNA) that remain after surgery or other cancer treatment. The announcement comes after several recent publications demonstrating the clinical utility of the RaDaR test, particularly in the breast cancer space,
Mar 13, 2023 07:00 am ET
NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP
FT. MYERS, FL / ACCESSWIRE / March 13, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today the expansion of their next-generation sequencing (NGS) portfolio of innovative products with the commercial availability of multiple tests, including Neo Comprehensive - Solid Tumor, a comprehensive genomic profile (CGP) for solid tumor cancers, and Neo Comprehensive - Myeloid Disorders, a CGP for myeloid neoplasms.
Feb 28, 2023 07:00 am ET
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
FT. MYERS, FL / ACCESSWIRE / February 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that Chris Smith, chief executive officer of NeoGenomics, and Jeff Sherman, chief financial officer, will participate in a fireside chat at the 44th Annual Raymond James Institutional Investors Conference on Monday, March 6, 2023 at 7:30am ET.
Feb 23, 2023 07:00 am ET
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results
Fourth Quarter Revenue Increased 10% to $139 million;
Feb 08, 2023 01:20 pm ET
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeoGenomics Laboratories, Inc. ("NeoGenomics" or "the Company") (NASDAQ: NEO). Investors who purchased NeoGenomics securities prior to November 9, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:
Feb 06, 2023 11:00 am ET
Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company) (NASDAQ: NEO) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired NeoGenomics common stock between February 27, 2020 through April 26, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Feb 06, 2023 10:00 am ET
DEADLINE ALERT for VERU and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 06, 2023 07:00 am ET
NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023
FT. MYERS, FL / ACCESSWIRE / February 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that it plans to release its fourth quarter and full year 2022, financial results on Thursday, February 23, 2023.
Feb 06, 2023 07:00 am ET
RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery
Newly-published data shows a strong link between tumor DNA circulating in blood and patient responses to investigational neoadjuvant treatment with immune therapies
Feb 04, 2023 06:00 am ET
NEOGENOMICS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Option
NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) and reminds investors of the February 6, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Feb 03, 2023 10:50 pm ET
NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenom
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company’s securities between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
Feb 03, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of F45 Training Holdings, Inc. (NYSE: FXLV), Silvergate Capital Corporation (NYSE:...
Feb 03, 2023 09:00 pm ET
NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired NeoGenomics securities between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”). Investors have until February 6, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Feb 03, 2023 01:00 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:
Feb 03, 2023 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Feb 02, 2023 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Feb. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Feb 01, 2023 09:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
CEDARHURST, N.Y., Feb. 1, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period"). Shareholders have until February 6, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Feb 01, 2023 11:00 am ET
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 01, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Feb 01, 2023 12:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Did you lose money on investments in NeoGenomics, Inc.? If so, please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 31, 2023 10:51 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the...
Jan 31, 2023 04:45 am ET
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging that the Company violated federal securities laws.
Jan 31, 2023 01:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 30, 2023 02:15 pm ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 30, 2023 10:00 am ET
GPS, NEO & NBEV Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 30, 2023 10:00 am ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Jan. 30, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Jan 30, 2023 05:02 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 30, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Attention NeoGenomics, Inc. ("NeoGenomics") (NASDAQ: NEO) shareholders:
Jan 29, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of F45 Training Holdings, Inc. (NYSE: FXLV), Silvergate Capital Corporation (NYSE:...
Jan 29, 2023 02:59 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980. The...
Jan 28, 2023 06:00 am ET
NEOGENOMICS SHAREHOLDER NOTICE:Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Opt
NEW YORK, Jan. 28, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) and reminds investors of the February 6, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Jan 27, 2023 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
NEW ORLEANS, Jan. 27, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
Jan 27, 2023 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- JAKUBOWITZ Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Jan 26, 2023 10:00 am ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Jan. 26, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Jan 26, 2023 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Jan 25, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Jan. 25, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Jan 24, 2023 10:38 pm ET
NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against...
Jan 24, 2023 08:52 pm ET
NEO INVESTOR ALERT: First and Only NeoGenomics Class Action Filed by Gibbs Law Group
Gibbs Law Group reminds investors it has filed the first and only class action lawsuit against NeoGenomics, Inc. (NASDAQ: NEO) and certain of its officers and directors on behalf of investors who purchased NeoGenomics securities from February 27, 2020, through April 26, 2022, inclusive. Investors have until February 6, 2023, to apply to be appointed as a lead plaintiff in the lawsuit.
Jan 24, 2023 01:00 pm ET
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 24, 2023 04:45 am ET
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging that the Company violated federal securities laws.
Jan 24, 2023 12:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Did you lose money on investments in NeoGenomics, Inc.? If so, please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 23, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of F45 Training Holdings, Inc. (NYSE: FXLV), Silvergate Capital Corporation (NYSE:...
Jan 23, 2023 01:00 pm ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 23, 2023 11:44 am ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 23, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 23, 2023 /PRNewswire/ -- Attention NeoGenomics, Inc. ("NeoGenomics") (NASDAQ: NEO) shareholders:
Jan 21, 2023 04:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980. The...
Jan 20, 2023 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
NEW ORLEANS, Jan. 20, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
Jan 20, 2023 03:58 pm ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Jan. 20, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Jan 20, 2023 10:00 am ET
GPS, NEO & NBEV Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 20, 2023 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 20, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Jan 19, 2023 11:11 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 20, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 19, 2023 07:51 pm ET
NEO INVESTOR ALERT: First and Only NeoGenomics Class Action Filed by Gibbs Law Group
Gibbs Law Group reminds investors it has filed the first and only class action lawsuit against NeoGenomics, Inc. (NASDAQ: NEO) and certain of its officers and directors on behalf of investors who purchased NeoGenomics securities from February 27, 2020, through April 26, 2022, inclusive. If any investor wishes to apply to be lead plaintiff, the deadline is February 6, 2023.
Jan 19, 2023 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Jan 18, 2023 10:30 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company’s securities between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”)....
Jan 18, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of F45 Training Holdings, Inc. (NYSE: FXLV), Silvergate Capital Corporation (NYSE:...
Jan 18, 2023 01:00 pm ET
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 18, 2023 11:30 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Did you lose money on investments in NeoGenomics, Inc.? If so, please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
Jan 18, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Jan. 18, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Jan 17, 2023 10:06 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the...
Jan 17, 2023 04:00 pm ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 17, 2023 12:05 pm ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 17, 2023 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NeoGenomics, Inc. (“NeoGenomics” or...
Jan 17, 2023 04:45 am ET
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders
NEW YORK, Jan. 17, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging that the Company violated federal securities laws.
Jan 16, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 16, 2023 /PRNewswire/ -- Attention NeoGenomics, Inc. ("NeoGenomics") (NASDAQ: NEO) shareholders:
Jan 13, 2023 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
NEW ORLEANS, Jan. 13, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Southern District of New York.
Jan 13, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Silvergate, NeoGenomics, Iris, and NewAge and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Silvergate Capital Corporation (NYSE: SI), NeoGenomics, Inc. (NASDAQ: NEO), Iris...
Jan 13, 2023 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 13, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Jan 12, 2023 07:15 pm ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Jan 12, 2023 05:45 pm ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Jan. 12, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Jan 12, 2023 12:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Did you lose money on investments in NeoGenomics, Inc.?  If so, please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.                                                                 
Jan 12, 2023 12:25 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 11, 2023 10:30 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
CEDARHURST, N.Y., Jan. 11, 2023 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  Shareholders have until February 6, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Jan 11, 2023 11:03 am ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 11, 2023 04:55 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Jan. 11, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Jan 10, 2023 02:37 pm ET
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 10, 2023 02:34 pm ET
ROSEN, A LONGSTANDING LAW FIRM, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”), of the important February 6,...
Jan 10, 2023 10:00 am ET
GPS, NEO & NBEV Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 10, 2023 04:45 am ET
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders
NEW YORK, Jan. 10, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging that the Company violated federal securities laws.
Jan 10, 2023 01:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 09, 2023 03:49 pm ET
NeoGenomics, Inc. (NEO) Class Action Notice: Contact Robbins LLP for Information Regarding the Class Action Against NeoGenomics, Inc.
The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired NeoGenomics, Inc. (NASDAQ: NEO) securities between February 27, 2020 and April 26, 2022, for...
Jan 09, 2023 03:33 pm ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Jan. 9, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Jan 09, 2023 02:25 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Jan 09, 2023 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 9, 2023 /PRNewswire/ -- Attention NeoGenomics, Inc. ("NeoGenomics") (NASDAQ: NEO) shareholders:
Jan 08, 2023 09:04 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of F45 Training Holdings, Inc. (NYSE: FXLV), Silvergate Capital Corporation (NYSE:...
Jan 06, 2023 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
NEW ORLEANS, Jan. 6, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Southern District of New York.
Jan 06, 2023 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NeoGenomics, Inc. (“NeoGenomics” or...
Jan 06, 2023 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Jan. 6, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Jan 05, 2023 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Jan. 5, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Jan 05, 2023 12:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Did you lose money on investments in NeoGenomics, Inc.?  If so, please visit NeoGenomics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.                                                                                     
Jan 04, 2023 10:59 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company’s securities between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”)....
Jan 04, 2023 09:02 pm ET
NEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired NeoGenomics securities between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”). Investors have until February 6, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Jan 04, 2023 11:46 am ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 04, 2023 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Jan. 4, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Jan 03, 2023 10:43 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the...
Jan 03, 2023 08:50 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Jan. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jan 03, 2023 12:30 pm ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 03, 2023 11:00 am ET
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 01, 2023 06:43 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Dec 31, 2022 02:48 pm ET
ROSEN, A LEADING LAW FIRM, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NEO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”), of the important February 6, 2023...
Dec 30, 2022 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
NEW ORLEANS, Dec. 30, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the Southern District of New York.
Dec 30, 2022 03:52 pm ET
NeoGenomics, Inc. (NEO) Class Action Alert: Robbins LLP Encourages Investors with Significant Losses in NeoGenomics, Inc. to Contact the Firm
The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired NeoGenomics, Inc. (NASDAQ: NEO) securities between February 27, 2020 and April 26, 2022, for...
Dec 29, 2022 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NeoGenomics, Inc. (“NeoGenomics”...
Dec 29, 2022 12:05 pm ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 29, 2022 10:00 am ET
GPS, NEO & NBEV Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Dec 29, 2022 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 29, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Dec 28, 2022 09:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
CEDARHURST, N.Y., Dec. 28, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  Shareholders have until February 6, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Dec 28, 2022 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Dec. 28, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Dec 27, 2022 10:53 pm ET
NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against...
Dec 27, 2022 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Dec. 27, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Dec 27, 2022 01:45 am ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Dec 26, 2022 04:47 pm ET
NEOGENOMICS INVESTOR ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Options
Dec 26, 2022 03:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Dec. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).  Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Dec 25, 2022 10:08 am ET
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NEO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”), of the important February 6,...
Dec 23, 2022 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
NEW ORLEANS, Dec. 23, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Southern District of New York.
Dec 22, 2022 11:45 am ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 22, 2022 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Dec 21, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company’s securities between February 27, 2020 and April 26, 2022, inclusive (the “Class Period”)....
Dec 21, 2022 08:48 pm ET
NEO INVESTOR ALERT: First And Only NeoGenomics Class Action Filed by Gibbs Law Group
Gibbs Law Group reminds investors it has filed the first and only class action lawsuit against NeoGenomics, Inc. (NASDAQ: NEO) and certain of its officers and directors on behalf of investors who purchased NeoGenomics securities from February 27, 2020 through April 26, 2022, inclusive. Since the lawsuit was filed, NeoGenomics subsidiary Inivata was also sued on December 21, 2022 for alleged patent infringement by genetic testing company Natera. NeoGenomics shares dropped 7% as a result, causing further harm to investors.
Dec 21, 2022 12:00 pm ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
LOS ANGELES, Dec. 21, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Dec 21, 2022 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Dec. 21, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Dec 20, 2022 10:42 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the...
Dec 20, 2022 04:30 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – NEO
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of NeoGenomics, Inc. (NASDAQ: NEO) between February 27, 2020 and April 26, 2022, both dates inclusive (the “Class Period”), of the important February 6,...
Dec 20, 2022 12:30 pm ET
NEOGENOMICS, INC. (NASDAQ: NEO) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ne
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Dec 20, 2022 12:00 pm ET
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 20, 2022 10:47 am ET
GPS, NEO & NBEV Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Dec 20, 2022 04:45 am ET
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders
NEW YORK, Dec. 20, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging that the Company violated federal securities laws.
Dec 19, 2022 09:55 pm ET
NEO INVESTOR ALERT: Gibbs Law Group Reminds NeoGenomics Investors of Class Action Deadline
Gibbs Law Group reminds investors it has filed the first and only class action lawsuit against NeoGenomics Inc. (NASDAQ: NEO) and certain of its officers and directors on behalf of investors who purchased NeoGenomics securities from February 27, 2020 through April 26, 2022, inclusive. After the lawsuit was filed, Seeking Alpha stated on December 9, 2022 that NeoGenomics’s “seemingly innocuous leadership transition” has turned “chaotic” and “toxic,” noting that its CFO Bill Bonnello stepped down on December 8, 2022. The class action lawsuit seeks to recover losses on behalf of NeoGenomics inves
Dec 19, 2022 04:48 pm ET
NEOGENOMICS INVESTOR ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In NeoGenomics To Contact Him Directly To Discuss Their Options
Dec 19, 2022 11:01 am ET
NeoGenomics, Inc. (NEO) Investor Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in Class Action Against NeoGenomics, Inc.
The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired NeoGenomics, Inc. (NASDAQ: NEO) securities between February 27, 2020 and April 26, 2022, for violations of the Securities Exchange Act of 1934. NeoGenomics provides cancer tests and testing
Dec 19, 2022 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind NeoGenomics Investors of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- Attention NeoGenomics, Inc. ("NeoGenomics") (NASDAQ: NEO) shareholders:
Dec 16, 2022 09:50 pm ET
NEOGENOMICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO
NEW ORLEANS, Dec. 16, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Southern District of New York.
Dec 16, 2022 12:00 pm ET
NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Dec. 16, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).
Dec 16, 2022 04:45 am ET
NEO SHAREHOLDER ALERT: Jakubowitz Law Reminds NeoGenomics Shareholders of a Lead Plaintiff Deadline of February 6, 2023
NEW YORK, Dec. 16, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO).
Dec 15, 2022 05:42 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980....
Dec 15, 2022 02:34 pm ET
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of NeoGenomics, Inc. (NEO) Investors and Encourages Investors to Contact the Firm Before February 6, 2023
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:...
Dec 15, 2022 11:40 am ET
DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Dec 15, 2022 11:00 am ET
Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against NeoGenomics, Inc. (“NeoGenomics” or the “Company) (NASDAQ: NEO) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired NeoGenomics common stock between February 27, 2020 through April 26, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Dec 15, 2022 04:45 am ET
NEO LAWSUIT ALERT: Levi & Korsinsky Notifies NeoGenomics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 15, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO) of a class action securities lawsuit.
Dec 15, 2022 02:00 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of NeoGenomics, Inc. - NEO
CEDARHURST, N.Y., Dec. 15, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of NeoGenomics, Inc. (NasdaqCM: NEO), if they purchased the Company's securities between February 27, 2020 and April 26, 2022, inclusive (the "Class Period").  Shareholders have until February 6, 2023 to file lead plaintiff applications in the securities class action lawsuit.
Dec 14, 2022 05:18 pm ET
NEO INVESTOR ALERT: Gibbs Law Group Has Filed a Class Action Lawsuit on Behalf of NeoGenomics Investors
Gibbs Law Group reminds investors it has filed the first and only class action lawsuit against NeoGenomics Inc. (NASDAQ: NEO) and certain of its officers and directors on behalf of investors who purchased NeoGenomics securities from February 27, 2020 through April 26, 2022, inclusive. After the lawsuit was filed, Seeking Alpha stated on December 9, 2022 that NeoGenomics’s “seemingly innocuous leadership transition” has turned “chaotic” and “toxic,” noting that its CFO Bill Bonnello stepped down on December 8, 2022. The class action lawsuit seeks to recover losses on behalf of NeoGenomics inves
Dec 14, 2022 09:00 am ET
NEOGENOMICS INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the South
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has filed in the United States District Court for the Southern District of New York against NeoGenomics Inc. (NASDAQ: NEO) (“NeoGenomics Inc.”) and...
Dec 14, 2022 04:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NeoGenomics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 6, 2023 - (NASDAQ: NEO)
NEW YORK, Dec. 14, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NeoGenomics, Inc..
Dec 13, 2022 10:56 pm ET
NEOGENOMICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 6, 2023 to file lead plaintiff applications in a securities class action lawsuit against...
Dec 13, 2022 07:30 pm ET
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 13, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or "the Company") (NASDAQ:NEO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Dec 13, 2022 03:00 pm ET
NEO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 6, 2023 in the Class Action Filed on Behalf of NeoGenomics, Inc. Shareholders
NEW YORK, Dec. 13, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NeoGenomics, Inc. (NASDAQ: NEO) alleging that the Company violated federal securities laws.
Dec 13, 2022 12:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 6, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:
Dec 12, 2022 10:05 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO
NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980.
Dec 12, 2022 08:30 pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 12, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or "the Company") (NASDAQ:NEO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.